Prognostic value of normal dobutamine stress echocardiography in renal transplant candidates

Nithima Chaowalit1, Maytinee Kittipovanonth, Khemajira Karaketklang

  • 1Division of Cardiology, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. sincw@mahidol.ac.th

Insights

Normal dobutamine stress echocardiography indicates a favorable long-term prognosis for patients awaiting kidney transplants. This cardiac screening tool helps assess cardiovascular risk in high-risk transplant candidates.

Area of Science:

  • Cardiology
  • Nephrology
  • Transplant Medicine

Background:

  • Renal transplant candidates face elevated risks of cardiovascular events.
  • Pre-operative cardiovascular evaluation lacks a definitive screening tool.

Purpose of the Study:

  • To assess the prognostic significance of dobutamine stress echocardiography in renal transplant candidates.
  • To determine the value of this non-invasive cardiac test in pre-operative evaluation.

Main Methods:

  • Dobutamine stress echocardiography was performed on 107 renal transplant candidates.
  • Mean follow-up duration was 2.8 years, with total mortality as the primary endpoint.

Main Results:

  • Overall survival probabilities at 1, 3, and 5 years were 87%, 83%, and 79%, respectively.
  • For patients who received transplants, survival rates at 1, 3, and 5 years were 100%, 100%, and 89%.

Conclusions:

  • A normal dobutamine stress echocardiography result predicts a good long-term prognosis in individuals undergoing renal transplant evaluation.
  • This non-invasive test can aid in risk stratification for this high-risk population.
Abstract